IL1B and COVID-19: Indeed, in COVID-19, very critical patients display a cytokine storm syndrome with an increased secretion of interleukin (IL)-6, IL-1β, IL-17, IL-8, tumor necrosis factor (TNF)-α, interferon (IFN)-γ and other pro-inflammatory mediators [1,2].